Search Results - "Moschen, A R"

Gut, inflammation and osteoporosis: basic and clinical concepts by Tilg, H, Moschen, A R, Kaser, A, Pines, A, Dotan, I

“…Chronic inflammatory disorders such as inflammatory bowel diseases (IBD) affect bone metabolism and are frequently associated with the presence of…”
Get more information

Adiponectin: key player in the adipose tissue-liver crosstalk by Moschen, A R, Wieser, V, Tilg, H

“…The adipose tissue has recently emerged as an important endocrine organ releasing numerous mediators including adipocytokines, classical cytokines and others…”
Get more information

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss by Moschen, A R, Kaser, A, Enrich, B, Ludwiczek, O, Gabriel, M, Obrist, P, Wolf, A M, Tilg, H

“…Background and aims: A substantial proportion of patients with inflammatory bowel disease (IBD) develops osteopenia and osteoporosis in the course of disease…”
Get full text

The role of apolipoprotein A5 in non-alcoholic fatty liver disease by Ress, C, Moschen, A R, Sausgruber, N, Tschoner, A, Graziadei, I, Weiss, H, Schgoer, W, Ebenbichler, C F, Konrad, R J, Patsch, J R, Tilg, H, Kaser, S

“…Apolipoprotein A5 (apoA5) is a recently described liver-specific protein that has been shown to influence triglyceride (TG) metabolism. ApoA5 transgenic mice…”
Get more information

Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients by Effenberger, M, Reider, S, Waschina, S, Bronowski, C, Enrich, B, Adolph, T E, Koch, R, Moschen, A R, Rosenstiel, P, Aden, K, Tilg, H

“…Graphical Abstract Summary of the primary point of “Microbial butyrate synthesis indicates therapeutic efficacy of azathioprine in IBD patients” Abstract…”
Get full text

Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease by Wolf, Anna Maria, Wolf, Dominik, Rumpold, Holger, Moschen, Alexander R., Kaser, Arthur, Obrist, Peter, Fuchs, Dietmar, Brandacher, Gerald, Winkler, Christiane, Geboes, Karel, Rutgeerts, Paul, Tilg, Herbert

“…T-cells are causally involved in the pathogenesis of inflammatory bowel disease (IBD). The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase (IDO)…”
Get full text

Liver complications in inflammatory bowel diseases by Wieser, V, Gerner, R, Moschen, A R, Tilg, H

“…Diseases of the liver and the biliary tract are commonly observed in patients with inflammatory bowel diseases (IBD). Besides primary sclerosing cholangitis…”
Get more information

Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trials by Gerner, R R, Moschen, A R, Tilg, H

“…Both innate and adaptive immunity play an important role in the pathogenesis of inflammatory bowel diseases (IBDs). There is strong evidence that especially…”
Get more information

Effect of weight loss on heme oxygenase-1 tissue expression by Ress, C, Moschen, A.R, Thoeni, V, Ebenbichler, C.F, Weiss, H, Molnar, C, Weiss, G, Tilg, H, Kaser, S

Get full text

Increased expression of CCL20 in human inflammatory bowel disease by Kaser, Arthur, Ludwiczek, Othmar, Holzmann, Sandra, Moschen, Alexander R, Weiss, Günter, Enrich, Barbara, Graziadei, Ivo, Dunzendorfer, Stefan, Wiedermann, Christian J, Mürzl, Elisabeth, Grasl, Eveline, Jasarevic, Zerina, Romani, Nikolaus, Offner, Felix A, Tilg, Herbert

“…Inflammatory bowel disease (IBD) constituting Crohn's disease (CD) and ulcerative colitis (UC) is related to a dysregulated T cell response. CCL20 attracts…”
Get full text

P905 Symptomatic remission and IUS improvements in a multi-national real-world cohort of UC patients treated with Upadacitinib - First results from the IBD-DACH study EUROPE by Zeissig, S, Schmelz, R, Helwig, U, Moschen, A R, Greuter, T, Fischer, I, Hammer, L, Rath, S, Kucharzik, T, Maaser, C

“…Abstract Background Upadacitinib (UPA) is an oral, reversible and selective Januskinase-inhibitor (JAKi) that was approved for the treatment of several…”
Get full text

P809 VARIETY BEACH: Real-world treatment patterns for vedolizumab intravenous and subcutaneous maintenance dosing observed over 1 year in studies from Belgium, Austria and Switzerland by Novacek, G, Hrúz, P, Högenauer, C, Louis, E, Vavricka, S R, Moschen, A R, Biedermann, L, Mächler, C, Stemberger, B, Van Gassen, G, Baert, F

“…Abstract Background Vedolizumab (VDZ) is approved for moderate to severe ulcerative colitis (UC) and Crohn’s disease (CD) as intravenous (IV) or subcutaneous…”
Get full text

Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways by Nairz, Manfred, Schroll, Andrea, Moschen, Alexander R., Sonnweber, Thomas, Theurl, Milan, Theurl, Igor, Taub, Nicole, Jamnig, Christina, Neurauter, Daniela, Huber, Lukas A., Tilg, Herbert, Moser, Patrizia L., Weiss, Günter

“…Erythropoietin (EPO) is the principal cytokine regulating erythropoiesis through its receptor, EPOR. Interestingly, EPORs are also found on immune cells with…”
Get full text

P034 A dietary fibre intervention shapes the microbiome towards an anti-inflammatory tone by Reider, S J, Moosmang, S, Tragust, J, Trgovec-Greif, L, Tragust, S, Przysiecki, N, Sturm, S, Tilg, H, Rattei, T, Stuppner, H, Moschen, A R

“…Abstract Background The intestinal microbiome in IBD shows characteristic changes already early in the course of disease. These include enrichment of…”
Get full text

DEFINING THE ROLE OF LIPOCALIN 2/LCN2 IN LIVER REGENERATION: 3072 by Kienzl, K., Moschen, A. R., Geiger, S., Brandacher, G., Aigner, F., Pratschke, J., Margreiter, R., Tilg, H.

Get full text

The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism by Demetz, Egon, Schroll, Andrea, Auer, Kristina, Heim, Christiane, Patsch, Josef R., Eller, Philipp, Theurl, Markus, Theurl, Igor, Theurl, Milan, Seifert, Markus, Lener, Daniela, Stanzl, Ursula, Haschka, David, Asshoff, Malte, Dichtl, Stefanie, Nairz, Manfred, Huber, Eva, Stadlinger, Martin, Moschen, Alexander R., Li, Xiaorong, Pallweber, Petra, Scharnagl, Hubert, Stojakovic, Tatjana, März, Winfried, Kleber, Marcus E., Garlaschelli, Katia, Uboldi, Patrizia, Catapano, Alberico L., Stellaard, Frans, Rudling, Mats, Kuba, Keiji, Imai, Yumiko, Arita, Makoto, Schuetz, John D., Pramstaller, Peter P., Tietge, Uwe J.F., Trauner, Michael, Norata, Giuseppe D., Claudel, Thierry, Hicks, Andrew A., Weiss, Guenter, Tancevski, Ivan

“…Cholesterol metabolism is closely interrelated with cardiovascular disease in humans. Dietary supplementation with omega-6 polyunsaturated fatty acids…”
Get full text

Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice by Wolf, Anna Maria, Wolf, Dominik, Avila, Matias A., Moschen, Alexander R., Berasain, Carmen, Enrich, Barbara, Rumpold, Holger, Tilg, Herbert

“…Recent reports suggest that the adipose tissue and adipokines are potent modulators of inflammation. However, there is only scarce knowledge on the functional…”
Get full text

Adiponectin and its receptors in patients with chronic hepatitis C by Jonsson, Julie R., Moschen, Alexander R., Hickman, Ingrid J., Richardson, Michelle M., Kaser, Susanne, Clouston, Andrew D., Powell, Elizabeth E., Tilg, Herbert

“…There is increasing interest in the influence of excess body weight and associated metabolic factors on the liver. In patients with non-alcoholic…”
Get full text

The RANKL/OPG system and bone mineral density in patients with chronic liver disease by Moschen, Alexander R., Kaser, Arthur, Stadlmann, Sylvia, Millonig, Gunda, Kaser, Susanne, Mühllechner, Petra, Habior, Andrzej, Graziadei, Ivo, Vogel, Wolfgang, Tilg, Herbert

“…Osteopenia and osteoporosis are common complications of chronic liver disease (CLD). Receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin…”
Get full text